“How wonderful to see and hear the top people in the PAH field.”

“Excellent presentations. Facility accommodations were excellent.”

-- from respondents to the meeting's exit questionnaire

“Thanks for a great conference and the excellent logistics.”

-- from a session chair

case studies

Frontiers

Evolution of Pulmonary Hypertension: Emerging Diseases and Novel Therapeutics

www.strategicresults.com/ph

Strategic Results adopted the pioneering vision of this fast-paced, quickly evolving field to organize a forum for leading experts from the international research and clinical communities.

Simply put, nothing has drawn as many physicians from across the country as this meeting. Project start to Finish: 12 weeks.

3 times the expected number of posters, thanks to targeted and effective marketing the “Call for Abstracts”
Three hundred percent increase in organizers’ expected number of participants
Facilitated the 20 travel awards
Coordinated sponsors:
- -NHLBI, NIH, DHHS
- -Office of Rare Diseases, OD, NIH, DHHS
- -Critical Care Medicine Department, NIH, DHHS
- -Pulmonary Hypertension Association
41 distinguished speakers from United States Congress, academic and clinical research, and patient advocacy
Ninety-seven percent of respondents to our exit questionnaire stated that they had acquired new concepts in basic and/or clinical research.

Program enhancements

Scripted the meeting program and talking points for session chairs
Managed CME credit process
Assisted members of Congress
Compassionate attention to patient participants
Compiled and distributed Executive Summary of meeting to showcase successes for sponsors and supporters
Wrote and presented how-to manuals on podium lectures and poster presentations for the Call for Abstracts
Developed and now maintain “must-see” PH information resources on the meeting web site
Managed meeting pod cast